Search

everythinglearnresearchcommunity

for

Search:↓

Topical finasteride with minoxidil is effective for treating hair loss and may reduce the need for oral finasteride.

New models predict male pattern baldness better than old ones but still need improvement.

Androgenetic alopecia severity does not affect COVID-19 severity.

No significant link between male pattern baldness and COVID-19 severity was found.

AC5 improves hair loss and hair quality with high satisfaction rates.

Trichoscopy effectively diagnoses and assesses the severity of androgenetic alopecia.

Rose stem cell exosomes can significantly improve hair growth in androgenetic alopecia.

Topical finasteride/minoxidil is effective but not better than oral finasteride for hair loss.

Identified genes linked to male-pattern baldness may help develop new treatments.

Certain peptides, caffeine, taurine, and an iron complex may improve hair regrowth when used with minoxidil and finasteride for hair loss.

About one-third of Saudi women with female pattern hair loss also have thinning hair at the back of their head.

Androgenetic alopecia is more common in Saudi men than women.

Hair transplants help transgender patients look more like their gender identity, with different procedures for trans women and men.

There's a significant link between severe hair loss and metabolic syndrome in Saudi Arabia, suggesting early health checks could prevent future issues.

Baldness is linked to a higher risk of coronary artery disease, but not to its severity.

Men with benign prostate hyperplasia have more meibomian gland loss and tear film problems.

Male pattern baldness may indicate arterial stiffness in transgender men on long-term testosterone therapy.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

More people are using online platforms for hair loss treatment due to convenience and privacy.

PRP treatment mildly to moderately improves hair loss in most men with AGA.

Higher platelet counts and activators in PRP improve hair density and thickness in treating hair loss.

Microneedling with PRP is as effective and safe as minoxidil+finasteride for treating hair loss.

Androgenetic alopecia negatively affects quality of life, especially in younger, less educated, single, and rural individuals.

Using lasers to deliver minoxidil can potentially improve its effectiveness in treating male pattern hair loss.

People with androgenetic alopecia have a higher risk of heart disease.

Men with early-onset hair loss have more heart disease risk factors.

Early-onset hair loss in young males is linked to a higher risk of metabolic syndrome.

Androgenetic alopecia is common in South-West Nigeria, affecting more men than women, with stress worsening the condition.